Update on the management of venous thromboembolism.

Authors:
John R Bartholomew
John R Bartholomew
Cleveland Clinic Foundation
United States

Cleve Clin J Med 2017 Dec;84(12 Suppl 3):39-46

Section Head, Department of Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disease associated with significant morbidity ranging from painful leg swelling, chest pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic pulmonary hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines.

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.84.s3.04DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
December 2017
14 Reads

Publication Analysis

Top Keywords

venous thromboembolism
8
thromboembolic pulmonary
4
chronic thromboembolic
4
syndrome chronic
4
embolism syndrome
4
pulmonary hypertension
4
postpulmonary embolism
4
syndrome pts
4
postthrombotic syndrome
4
hypertension postthrombotic
4
pts management
4
vte postpulmonary
4
shortness breath
4
pain shortness
4
chest pain
4
breath death
4
death long-term
4
include recurrent
4
complications include
4
long-term complications
4

Similar Publications